Fujii et al., 2000 - Google Patents
Localization of biologically uncommon D-beta-aspartate-containing alphaA-crystallin in human eye lensFujii et al., 2000
View PDF- Document ID
- 4941334771651490314
- Author
- Fujii N
- Shimo-Oka T
- Ogiso M
- Momose Y
- Kodama T
- Kodama M
- Akaboshi M
- Publication year
- Publication venue
- Mol Vis
External Links
Snippet
Purpose: Previous studies demonstrated that the Asp-151 residue of αA-crystallin from human eye lens is stereoinverted to the biologically uncommon D-isomer and isomerized to the β-aspartyl residue (isoaspartate) with age. To detect the locality of the D-β-Asp …
- 241000282414 Homo sapiens 0 title abstract description 53
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0683234B1 (en) | Antibody against beta-amyloid or their derivative and use thereof | |
| US5955317A (en) | Antibodies to β-amyloids or their derivatives and use thereof | |
| JP2537589B2 (en) | Improved antibodies against Plasmodium falciparum | |
| Muller et al. | Comparison of different methods for localizing antigenic regions in histone H2A | |
| Miller et al. | Antibodies directed against N-terminal residues on actin do not block acto-myosin binding | |
| Fujii et al. | Localization of biologically uncommon D-beta-aspartate-containing alphaA-crystallin in human eye lens | |
| JP3107225B2 (en) | Antibodies against PACAP and uses thereof | |
| US5173422A (en) | Monoclonal antibodies specific for human glycoalbumin | |
| Hargrave et al. | Rhodopsin's amino terminus is a principal antigenic site | |
| US5225354A (en) | Monoclonal antibodies specific for human glycoalbumin | |
| CN112457392B (en) | Soluble ST2 protein antigenic determinant polypeptide and application thereof | |
| JP4374316B2 (en) | Antibody to β-amyloid or a derivative thereof and use thereof | |
| JP4318458B2 (en) | pan-specific monoclonal antibody | |
| JP3978226B2 (en) | Immunoassay to identify alcoholics and monitor alcohol consumption | |
| JP3894381B2 (en) | Anti-Glu ▲ 17 ▼ -osteocalcin antibody | |
| JPH02276591A (en) | Monoclonal antibody recognizing c end side of anp | |
| JPH0949836A (en) | Method for evaluating protein structure by antibody | |
| US9067982B2 (en) | Compositions and methods for redox modulated proteins | |
| ES2275924T3 (en) | COMPOSITIONS AND METHODS TO TEST AA4RP. | |
| KR20190038001A (en) | Method for producing polyclonal antibody against GIGANTEA protein from Arabidopsis thaliana | |
| JP3167024B2 (en) | Monoclonal antibodies against endothelin-3 or endothelin-3 precursor and uses thereof | |
| WO1987007147A1 (en) | Method for producing monoclonal antibodies to an immunogenic antibody-antigen conjunction | |
| JPH11140098A (en) | Method for producing anti-peptide antibody | |
| JP3419746B2 (en) | Monoclonal antibody against endothelin-3 precursor and use thereof | |
| Deshmukh et al. | Development and characterization of monoclonal antibodies to chicken riboflavin carrier protein |